Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...
PHILADELPHIA, PA & SAN FRANCISCO, CA — Dispatch Bio said the U.S. Food and Drug Administration has cleared its ...
BHUBANESWAR: In a major boost to hematology and cancer care in Odisha, Utkal Hospital on Thursday launched a well-structured clinical hematology department offe ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...
Patients with Waldenström Non-Hodgkin lymphoma in the U.S. achieved durable complete responses of up to 15 months using a chemotherapy-free CD19 CAR-NK (chimeric antigen receptor natural killer) cell ...
The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...
Dr. Veena Joy shares her path to industry, advances in autoimmune diagnostics, CAR-T potential, health economics, and equity in women's health.
The Food and Drug Administration (FDA) has approved Breyanzi ® (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) ...
Measles cases are surging in the U.S., partly fueled by claims that infection boosts immunity or fights cancer. Here’s what ...
The "Cell & Gene Therapy Cold Chain Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback